Evidence map›Paper›PMID 31451722›Full record

ArticleScientific reports2019

Fast LC-ESI-MS/MS analysis and influence of sampling conditions for gut metabolites in plasma and serum.

Tom van der Laan, Tim Kloots, Marian Beekman, Alida Kindt, Anne-Charlotte Dubbelman, Amy Harms, Cornelia M van Duijn, P Eline Slagboom, Thomas Hankemeier

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. TrimethylamineScience advances · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Tom van der LaanAnalytical Biosciences and Metabolomics, Division of Systems Biomedicine and Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Leiden, 2333 CC, The Netherlands.
Tim KlootsAnalytical Biosciences and Metabolomics, Division of Systems Biomedicine and Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Leiden, 2333 CC, The Netherlands.
Marian BeekmanSection of Molecular Epidemiology, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.ORCID http://orcid.org/0000-0003-0585-6206
Alida KindtAnalytical Biosciences and Metabolomics, Division of Systems Biomedicine and Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Leiden, 2333 CC, The Netherlands.
Anne-Charlotte DubbelmanAnalytical Biosciences and Metabolomics, Division of Systems Biomedicine and Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Leiden, 2333 CC, The Netherlands.
Amy HarmsAnalytical Biosciences and Metabolomics, Division of Systems Biomedicine and Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Leiden, 2333 CC, The Netherlands.ORCID http://orcid.org/0000-0002-2931-4295
Cornelia M van DuijnDepartment of Epidemiology, Erasmus University Medical Centre, Rotterdam, 3015 GE, The Netherlands.
P Eline SlagboomSection of Molecular Epidemiology, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Thomas HankemeierAnalytical Biosciences and Metabolomics, Division of Systems Biomedicine and Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Leiden, 2333 CC, The Netherlands. hankemeier@lacdr.leidenuniv.nl.
Leiden University · NLLeiden University Medical Center · NLErasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past few years, the gut microbiome has been shown to play an important role in various disorders including in particular cardiovascular diseases. Especially the metabolite trimethylamine-N-oxide (TMAO), which is produced by gut microbial metabolism, has repeatedly been associated with an increased risk for cardiovascular events. Here we report a fast liquid chromatography tandem mass spectrometry (LC-MS/MS) method that can analyze the five most important gut metabolites with regards to TMAO in three minutes. Fast liquid chromatography is unconventionally used in this method as an on-line cleanup step to remove the most important ion suppressors leaving the gut metabolites in a cleaned flow through fraction, also known as negative chromatography. We compared different blood matrix types to recommend best sampling practices and found citrated plasma samples demonstrated lower concentrations for all analytes and choline concentrations were significantly higher in serum samples. We demonstrated the applicability of our method by investigating the effect of a standardized liquid meal (SLM) after overnight fasting of 25 healthy individuals on the gut metabolite levels. The SLM did not significantly change the levels of gut metabolites in serum.

Indexed as

MetabolomeSpectrometry, Mass, Electrospray IonizationTandem Mass SpectrometryBiosynthetic PathwaysBlood Specimen CollectionCalibrationFastingFemaleFreezingGastrointestinal TractHumansMaleMethylaminesMiddle AgedPlasmaReference StandardsMethylaminestrimethyloxamine

Identifiers

PMID31451722
PMCPMC6710273
OpenAlexW2969540729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.